HCP, Inc. (HCP) Position Boosted by Zevin Asset Management LLC

Zevin Asset Management LLC boosted its position in HCP, Inc. (NYSE:HCP) by 37.3% in the fourth quarter, HoldingsChannel reports. The firm owned 127,396 shares of the real estate investment trust’s stock after buying an additional 34,597 shares during the quarter. HCP comprises approximately 1.3% of Zevin Asset Management LLC’s investment portfolio, making the stock its 28th largest position. Zevin Asset Management LLC’s holdings in HCP were worth $3,558,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HCP. Private Ocean LLC raised its holdings in HCP by 251.7% in the fourth quarter. Private Ocean LLC now owns 1,674 shares of the real estate investment trust’s stock worth $47,000 after purchasing an additional 1,198 shares in the last quarter. Nvwm LLC bought a new position in HCP in the fourth quarter worth $48,000. Capital Investment Advisory Services LLC bought a new position in HCP in the fourth quarter worth $102,000. CWM LLC raised its holdings in HCP by 9.2% in the fourth quarter. CWM LLC now owns 4,064 shares of the real estate investment trust’s stock worth $114,000 after purchasing an additional 341 shares in the last quarter. Finally, Private Capital Group LLC raised its holdings in HCP by 71.4% in the fourth quarter. Private Capital Group LLC now owns 4,286 shares of the real estate investment trust’s stock worth $120,000 after purchasing an additional 1,786 shares in the last quarter. Institutional investors and hedge funds own 88.78% of the company’s stock.

A number of research firms have issued reports on HCP. BMO Capital Markets upgraded HCP from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $30.00 to $33.00 in a report on Wednesday, January 9th. Robert W. Baird raised HCP from a “neutral” rating to an “outperform” rating in a research note on Monday, January 7th. Scotiabank started coverage on HCP in a research note on Monday, December 10th. They issued an “outperform” rating and a $32.00 target price on the stock. Zacks Investment Research reissued a “sell” rating on shares of HCP in a research note on Tuesday, November 13th. Finally, ValuEngine raised HCP from a “hold” rating to a “buy” rating in a research note on Monday, November 12th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $27.39.

Shares of NYSE HCP traded down $0.01 during trading on Monday, reaching $31.24. The company had a trading volume of 34,949 shares, compared to its average volume of 2,699,802. HCP, Inc. has a 12-month low of $21.48 and a 12-month high of $31.65. The stock has a market cap of $14.85 billion, a P/E ratio of 16.02, a P/E/G ratio of 13.87 and a beta of 0.46. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 1.21.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 28th. Investors of record on Tuesday, February 19th will be given a dividend of $0.37 per share. The ex-dividend date of this dividend is Friday, February 15th. This represents a $1.48 annualized dividend and a dividend yield of 4.74%. HCP’s dividend payout ratio (DPR) is presently 75.90%.

In related news, COO Thomas Klaritch sold 82,532 shares of the stock in a transaction on Tuesday, December 4th. The stock was sold at an average price of $29.51, for a total transaction of $2,435,519.32. Following the sale, the chief operating officer now directly owns 256,280 shares of the company’s stock, valued at $7,562,822.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.14% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “HCP, Inc. (HCP) Position Boosted by Zevin Asset Management LLC” was posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this report on another publication, it was stolen and republished in violation of United States & international copyright and trademark laws. The correct version of this report can be viewed at https://www.thelincolnianonline.com/2019/02/11/hcp-inc-hcp-position-boosted-by-zevin-asset-management-llc.html.

HCP Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Read More: What is a Market Correction?

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply